| Bezafibrate | Control | p |
---|---|---|---|
Body mass index (kg/m2) | 28.8 ± 1.2 | 28.6 ± 1.1 | 0.24 |
Systolic blood pressure (mmHg) | 127 ± 4 | 125 ± 4 | 0.34 |
Diastolic blood pressure (mmHg) | 78 ± 3 | 80 ± 2 | 0.98 |
Heart rate (beats/min) | 64 ± 2 | 65 ± 1 | 0.20 |
Laboratory data | Â | Â | Â |
Total-C (mg/dl) | 217 ± 9 | 197 ± 8 | 0.02 |
LDL-C (mg/dl) | 129 ± 6 | 135 ± 9 | 0.57 |
HDL-C (mg/dl) | 46 ± 3 | 43 ± 3 | 0.22 |
TG (mg/dl) | 135 ± 24 | 203 ± 35 | <0.01 |
RLP-C (mg/dl) | 5.7 ± 0.7 | 7.9 ± 1.3 | 0.02 |
ApoB-48 (μg/ml) | 3.5 ± 0.7 | 6.0 ± 1.5 | 0.02 |
Glucose (mg/dl) | 97 ± 3 | 101 ± 5 | 0.15 |
Insulin (μU/ml) | 12.7 ± 4.8 | 8.5 ± 1.4 | 0.43 |
HOMA-IR | 2.9 ± 0.2 | 2.1 ± 0.2 | 0.48 |
Hemoglobin A1c (%) | 5.2 ± 0.3 | 5.3 ± 0.3 | 0.17 |
Pentraxin 3 (ng/ml) | 1.5 ± 0.2 | 1.5 ± 0.2 | 0.64 |
Endothelial function | Â | Â | Â |
Brachial artery diameter (mm) | 4.3 ± 0.2 | 4.3 ± 0.2 | 0.70 |
% FMD | 6.9 ± 0.7 | 5.9 ± 0.7 | 0.04 |